SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Jones Jeffrey Michael (Last) (First) (Middle) C/O PHARMATHENE, INC., ONE PARK PLACE, SUITE 450 (Street) ANNAPOLIS MD 21401 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 03/11/2015	3. Issuer Name and Ticker or Trading Symbol PHARMATHENE, INC [ PIP ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) COO	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.0001 per share	2,544	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Purchase Option	(1)	04/25/2015	Common Stock	2,484	3.8	D
Stock Purchase Option	(2)	02/22/2016	Common Stock	1,076	3.81	D
Stock Purchase Option	(3)	10/02/2017	Common Stock	11,838	5.2	D
Stock Purchase Option	(4)	01/21/2019	Common Stock	4,969	2.46	D
Stock Purchase Option	(5)	05/06/2020	Common Stock	10,000	1.38	D
Stock Purchase Option	(6)	12/08/2020	Common Stock	3,797	3.55	D
Stock Purchase Option	(7)	12/08/2020	Common Stock	1,266	3.55	D
Stock Purchase Option	(8)	09/30/2021	Common Stock	20,000	1.76	D
Stock Purchase Option	(9)	12/01/2021	Common Stock	5,625	1.21	D
Stock Purchase Option	(10)	12/01/2021	Common Stock	3,830	1.21	D
Stock Purchase Option	(11)	12/03/2022	Common Stock	5,063	1.13	D
Stock Purchase Option	(12)	01/29/2024	Common Stock	6,188	1.94	D
Stock Purchase Option	(13)	03/27/2024	Common Stock	15,000	1.83	D
Stock Purchase Option	(14)	12/08/2024	Common Stock	30,000	1.71	D

Explanation of Responses:

1. These options became exercisable in 4 equal annual installments, with the first installment exercisable on April 25, 2006.

2. These options became exercisable as follows: 25% on February 22, 2006, and the remaining 75% in 36 equal monthly installments, beginning March 22, 2006.

3. These options became exercisable as follows: 20% on October 2, 2007, 20% on October 2, 2008 and the remainder in 36 equal monthly installments, beginning November 2, 2008.

4. These options became exercisable in 4 equal annual installments, with the first installment exercisable on January 21, 2010.

5. These options became exercisable in 4 equal annual installments, with the first installment exercisable on May 6, 2011.

6. These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 8, 2011.

7. These options became exercisable on December 8, 2010.

8. These options became exercisable on September 30, 2012.

9. These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 1, 2011.

10. These options became exercisable on December 1, 2012.

11. These options are exercisable in 4 equal annual installments, with the first installment exercisable on December 3, 2012.

12. These options are exercisable in 4 equal annual installments, with the first installment exercisable on January 29, 2014.

13. These options are exercisable in 4 equal annual installments, with the first installment exercisable on March 27, 2015.

14. These options are exercisable in 4 equal annual installments, with the first installment exercisable on December 8, 2014.

	/s/ Jeffrey Jones	03/27/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.